These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 23399986

  • 21. Lymph node standardized uptake values at pre-treatment 18F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma.
    Jeong Y, Baek S, Park JW, Joo JH, Kim JS, Lee SW.
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [Abstract] [Full Text] [Related]

  • 22. Comparison of prognostic values of primary tumor and nodal 18F-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease.
    Lim CH, Hyun SH, Moon SH, Cho YS, Choi JY, Lee KH.
    Eur Radiol; 2019 Oct; 29(10):5288-5297. PubMed ID: 30899978
    [Abstract] [Full Text] [Related]

  • 23. Risk factors for mediastinal lymph node metastasis in non-small-cell lung cancer by PET/CT.
    Xu ZQ, Xie LJ, Fan W, Duan XB, Cheng MH.
    Nucl Med Commun; 2014 May; 35(5):466-71. PubMed ID: 24535381
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer.
    Yang DD, Mirvis E, Goldring J, Patel ARC, Wagner T.
    Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
    [Abstract] [Full Text] [Related]

  • 26. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.
    Li M, Liu N, Hu M, Shi F, Yuan S, Zhang P, Fu Z, Yang G, Yu J.
    Lung Cancer; 2009 Mar; 63(3):383-6. PubMed ID: 18635284
    [Abstract] [Full Text] [Related]

  • 27. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 28. Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy.
    Tanaka H, Hayashi S, Hoshi H.
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e113-7. PubMed ID: 24176011
    [Abstract] [Full Text] [Related]

  • 29. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.
    Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
    [Abstract] [Full Text] [Related]

  • 30. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW, Na JO, Kang DY, Lee SY, Lee SM.
    Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.
    Um SW, Kim H, Koh WJ, Suh GY, Chung MP, Kwon OJ, Choi JY, Han J, Lee KS, Kim J.
    J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106
    [Abstract] [Full Text] [Related]

  • 32. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
    Nair VJ, MacRae R, Sirisegaram A, Pantarotto JR.
    Int J Radiat Oncol Biol Phys; 2014 Feb 01; 88(2):312-8. PubMed ID: 24411602
    [Abstract] [Full Text] [Related]

  • 33. Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer.
    Domachevsky L, Groshar D, Galili R, Saute M, Bernstine H.
    Eur Radiol; 2015 Nov 01; 25(11):3361-7. PubMed ID: 25929940
    [Abstract] [Full Text] [Related]

  • 34. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
    Park SY, Yoon JK, Park KJ, Lee SJ.
    Cancer Imaging; 2015 Dec 22; 15():21. PubMed ID: 26694918
    [Abstract] [Full Text] [Related]

  • 35. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
    Kuo WH, Wu YC, Wu CY, Ho KC, Chiu PH, Wang CW, Chang CJ, Yu CT, Yen TC, Lin C.
    Acad Radiol; 2012 Jun 22; 19(6):685-92. PubMed ID: 22459646
    [Abstract] [Full Text] [Related]

  • 36. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
    Liu J, Li C, Hu M, Lu J, Shi X, Xing L, Sun X, Fu Z, Yu J, Meng X.
    Medicine (Baltimore); 2015 May 22; 94(17):e678. PubMed ID: 25929896
    [Abstract] [Full Text] [Related]

  • 37. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Mattes MD, Moshchinsky AB, Ahsanuddin S, Rizk NP, Foster A, Wu AJ, Ashamalla H, Weber WA, Rimner A.
    Clin Lung Cancer; 2015 Nov 22; 16(6):e253-8. PubMed ID: 26163919
    [Abstract] [Full Text] [Related]

  • 38. Primary tumor standardized uptake value (SUVmax) measured on 18F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer.
    Hui Z, Wei F, Ren H, Xu W, Ren X.
    J Cancer Res Clin Oncol; 2020 Oct 22; 146(10):2595-2605. PubMed ID: 32494919
    [Abstract] [Full Text] [Related]

  • 39. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
    Vural GU, Akkas BE, Demirel BB.
    Rev Esp Med Nucl Imagen Mol; 2014 Oct 22; 33(5):268-73. PubMed ID: 25018135
    [Abstract] [Full Text] [Related]

  • 40. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
    Yoshioka M, Ichiguchi O.
    Ann Thorac Cardiovasc Surg; 2009 Apr 22; 15(2):82-8. PubMed ID: 19471220
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.